Antiemetic: Clinical Trials

3 trials for Antiemetic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 1 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 31Completed 1
Phase 41Unknown 1

Follow Antiemetic: new trials by email Literature Review of Antiemetic trials Research Report on Antiemetic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer
Fosaprepitant, tropisetron, Dexamethasone - Cervical Cancer, Nasopharyngeal Cancer
Phase 3CompletedShantou University Medical College1162021-07-012024-02-06
Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP
Ondansetron 4 mg, Palonosetron 75 mcg - Antiemetic, Postoperative Nausea and Vomiting
Phase 4UnknownTheodor Bilharz Research Institute902020-10-242020-10-06
The Antigagging Effect of Granisetron (Kytril), an Antiemetic Drug, in Dental Situations
GRANISETRON - Antiggaging Effect, Antiemetic
Not applicableUnknownHadassah Medical Organization2010-11-30

Narrower conditions

Gagging (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vomiting (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Signs and Symptoms, Digestive (3)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Head and Neck Neoplasms (1)  ·  Nasopharyngeal Diseases (1)  ·  Nausea (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)

Interventions

Dexamethasone (1)  ·  Granisetron (1)  ·  Ondansetron (1)  ·  Palonosetron (1)  ·  Tropisetron (1)  ·  fosaprepitant (1)

Sponsors

Hadassah Medical Organization (1)  ·  Shantou University Medical College (1)  ·  Theodor Bilharz Research Institute (1)

Countries

China (1)  ·  Israel (1)

Top investigators

Chuangzhen Chen (1)  ·  Eliezer Kaufman, DMD (1)  ·  Omar M. Abou-Hashim, residant (1)  ·  Yahia M. Hammad, Lecteurer (1)

Results publications

PMID 37851143